Tirbanibulin
Tirbanibulin (KX2-391) is a substrate-targeted, highly selective Src kinase inhibitor. It has shown anti-tumor efficacy in preclinical in vivo models of colon, pancreatic, prostate, and breast cancers, supporting its investigation as a targeted protein kinase inhibitor in oncology research.
Product Specifications
CAS Number
897016-82-9
Product Name Alternative
Inhibitor, inhibit, KX 01, KX-01, KX01, KX2-391, Microtubule Associated, Microtubule/Tubulin, MicrotubuleAssociated, Src, Src (Hep 3B), Src (Hep G2), Src (HuH7), Src (PLC/PRF/5), Tirbanibulin
Field of Research
Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.43% (May vary between batches)
Solubility
DMSO:84.17 mg/mL (195.05 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.65 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
O=C (Cc1ccc (cn1) -c1ccc (OCCN2CCOCC2) cc1) NCc1ccccc1
Molecular Formula
C26H29N3O3
Molecular Weight
431.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog